These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 423599)

  • 1. Myocardial protection.
    Lolley DM; Ray JF; Meyers WO; Sautter RD
    J Thorac Cardiovasc Surg; 1979 Apr; 77(4):631-3. PubMed ID: 423599
    [No Abstract]   [Full Text] [Related]  

  • 2. Myocardial protection during ischemic cardiac arrest. Possible deleterious effects of glucose and mannitol in coronary infusates.
    Hearse DJ; Stewart DA; Braimbridge MV
    J Thorac Cardiovasc Surg; 1978 Jul; 76(1):16-23. PubMed ID: 661362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of the immature myocardium during ischemic arrest: dose dependent effects of glucose and mannitol when added to St Thomas' cardioplegic solution.
    Yang SS; Hearse DJ
    Can J Cardiol; 1989; 5(8):401-7. PubMed ID: 2514036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of myocardial protection during open heart surgery in infants with ventricular septal defect].
    Ishihara K; Sakahashi H; Noji S; Nonoyama M; Maki S; Kubo E; Ohta J; Aoki M; Shinoka T; Koh E
    Rinsho Kyobu Geka; 1988 Dec; 8(6):575-7. PubMed ID: 9301885
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimal myocardial preservation: cooling, cardioplegia, and conditioning.
    Cleveland JC; Meldrum DR; Rowland RT; Banerjee A; Harken AH
    Ann Thorac Surg; 1996 Feb; 61(2):760-8. PubMed ID: 8572815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cold cardioplegia or continuous coronary perfusion? Report on preliminary clinical experience as assessed cytochemically.
    Braimbridge MV; Chayen J; Bitensky L; Hearse DJ; Jynge P; Canković-Darracott S
    J Thorac Cardiovasc Surg; 1977 Dec; 74(6):900-6. PubMed ID: 926815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of myocardial protection in infancy during last 3 years].
    Kadoba K; Hirose H; Matsuda H; Shirakura R; Maeda S; Kishimoto H; Ohtani M; Kaneko M; Sasako Y; Kawashima Y
    Rinsho Kyobu Geka; 1985; 5(2):162-7. PubMed ID: 9422998
    [No Abstract]   [Full Text] [Related]  

  • 8. Myocardial protection.
    Bretschneider HJ
    Thorac Cardiovasc Surg; 1980 Oct; 28(5):295-302. PubMed ID: 6161427
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biochemical and morphological investigations on the human heart in cardioplegia and profound hypothermia (author's transl)].
    Döring V; Bleese N; Lierse W; Pokar H
    Thoraxchir Vask Chir; 1978 Dec; 26(6):449-57. PubMed ID: 751289
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of verapamil on myocardial tolerance to ischemic arrest: comparison to potassium arrest.
    Robb-Nicholson C; Currie WD; Wechsler AS
    Circulation; 1978 Sep; 58(3 Pt 2):I119-24. PubMed ID: 14740691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of mannitol on the performance of the isolated canine heart after fibrillatory arrest.
    Weisfeldt ML; Scully HE; Selden R; Bello AG; Powell WJ; Daggett WM
    J Thorac Cardiovasc Surg; 1973 Aug; 66(2):290-9. PubMed ID: 4720982
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental study on the efficacy of the combined use of Young's solution in myocardial protection by asanguinous cardioplegia].
    Shikano K; Nasu M; Miyamura K; Sakai T; Shomura S; Kusagawa M; Hidaka H
    Kyobu Geka; 1983 Jun; 36(6):474-8. PubMed ID: 6632422
    [No Abstract]   [Full Text] [Related]  

  • 13. Advantages of blood cardioplegia over continuous coronary perfusion or intermittent ischemia. Experimental and clinical study.
    Follette DM; Mulder DG; Maloney JV; Buckberg GD
    J Thorac Cardiovasc Surg; 1978 Nov; 76(5):604-19. PubMed ID: 703365
    [No Abstract]   [Full Text] [Related]  

  • 14. Myocardial protection with cold, ischemic, potassium-induced cardioplegia.
    Roe BB; Hutchinson JC; Fishman NH; Ullyot DJ; Smith DL
    J Thorac Cardiovasc Surg; 1977 Mar; 73(3):366-74. PubMed ID: 839826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myocardial protection in cardiac surgery. Comparison of 2 cardioplegic solutions].
    Pereira SN; Ribeiro CT; Raiser AG; Tabone EJ; Andujar MB; Marques RS
    Arq Bras Cardiol; 1983 Apr; 40(4):255-8. PubMed ID: 6661085
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic modulation for cardiac protection.
    Weinberg GL; Massad MG
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):135-8. PubMed ID: 17338658
    [No Abstract]   [Full Text] [Related]  

  • 17. Progress in myocardial protection during cardiac operations.
    Buckberg GD
    Cardiovasc Clin; 1981; 12(3):9-30. PubMed ID: 7044544
    [No Abstract]   [Full Text] [Related]  

  • 18. Regional myocardial protection: use of a new method to compare cold potassium cardioplegia with hypothermic coronary perfusion.
    Guyton RA; Jacobs ML; Fowler BN; Geffin GA; O'Keefe DD; Daggett WM
    Circulation; 1980 Aug; 62(2 Pt 2):I26-33. PubMed ID: 7397996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of myocardial function not enhanced by high concentrations of potassium during cardioplegic arrest.
    Ellis RJ; Mangano DT; Van Dyke DC; Ebert PA
    J Thorac Cardiovasc Surg; 1979 Nov; 78(5):698-707. PubMed ID: 491723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of cardioplegic solutions on coronary and myocardial ultrastructure. Preliminary note].
    Macchiarelli G; Chiavarelli R; Macchiarelli A; Chiavarelli M; Toscano M; Carpi A; Marino B
    G Ital Cardiol; 1983 Aug; 13(8):106-12. PubMed ID: 6418607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.